Write in a clean editor, then format for Current Problems in Cancer Case Reports in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Current Problems in Cancer Case Reports is a peer-reviewed journal published by Elsevier, covering Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Neuroendocrine Tumor Research Advances.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Current Problems in Cancer Case Reports 12 (2023) 45–58.
Formats any DOI in Current Problems in Cancer Case Reports style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Neuroendocrine Tumor Research Advances Cancer and Skin Lesions Chronic Lymphocytic Leukemia Research |
| ISSN | 2666-6219 |
| Citation impact (2-yr) | 0.35 |
| h-index | 8 |
| i10-index | 6 |
| Total citations | 427 |
| Article processing charge | $650 |
| Open access | Yes |
| Top institutions publishing here | Northwell Health |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Breast cancer is the most common malignancy among women worldwide, often characterized by the uncontrolled proliferation of breast cells, leading to the formation of lumps or tumors that can be detected through medical imaging such as X-rays. Distinguishing between benign and malignant tumors presents a significant challenge in the diagnosis of breast cancer. In this…
Introduction COVID-19 disease has caused a global health and economic crisis. The introduction of the different COVID-19 vaccines has resulted in a significant decrease in the morbidity and mortality associated with this disease. Adverse effects have been reported, including cardiological ones such as myocarditis or pericarditis after administration. Likewise, tyrosine kinase inhibitor drugs such as…
Axillary lymphadenopathy ipsilateral to the vaccination site has been clinically and radiologically reported after administration of COVID-19 vaccines. This can be an important diagnostic dilemma, particularly in cancer patients who are being staged or re-staged, as this benign entity may mimic metastasis, cause unnecessary biopsies and changes in therapy. Here we present a breast cancer…
The coronavirus disease 19 (COVID-19) pandemic has infected tens of millions across the world, but there is a significant gap in our understanding about COVID-19 in the hematopoietic stem transplant (HSCT) recipient population. Prolonged viral shedding is frequently observed with severe acute respiratory syndrome coronavirus-2 (SARSCoV-2), but studies suggest viral loads decline 10 days after…
FDG PET CT in the left axilla of a woman being treated for metastatic breast cancer after COVID-19 vaccination. Follow-up ultrasound of the axilla indicated no metastasis, indicating that the lymphadenopathy was likely due to an immune response following vaccination. This case report, in conjunction with prior studies of other vaccines with similar findings suggest…
